Gout in the UK and Germany: Prevalence and Management
Author Information
Author(s): Annemans L, Spaeten E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G
Primary Institution: IMS Health, Brussels, Belgium
Hypothesis
To investigate and compare the prevalence, comorbidities and management of gout in practice in the UK and Germany.
Conclusion
The prevalence of gout in practice in the UK and Germany from 2000 to 2005 was 1.4%, with chronic comorbidities being common among patients.
Supporting Evidence
- The prevalence of gout was found to be 1.4% in both the UK and Germany.
- Obesity was the most common comorbidity in the UK, while diabetes was most common in Germany.
- Patients with higher serum uric acid levels had an increased risk of gout flares.
Takeaway
Gout is a common condition in the UK and Germany, affecting about 1 in 100 people, and many patients also have other health issues like obesity and diabetes.
Methodology
A retrospective analysis of patient records from general practices in the UK and Germany using the IMS Disease Analyzer.
Limitations
The study may have underestimated the prevalence of gout in Germany and did not account for all gout flares due to self-medication.
Participant Demographics
Over 80% of the study population was male, with mean ages of 66 years in the UK and 63 years in Germany.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website